About ▼ Careers Internship MedBlog Contact us
English (US) ▼
Medindia
LOGIN REGISTER
Medindia

Mesothelioma News, Research and Latest Updates

Keep abreast with the latest news related to Mesothelioma there are 62 news items on Mesothelioma that covers updates, breakthroughs and in-depth reports.

We provide you with a free downloadable secure widget for your website to carry news related to Mesothelioma.

Mesothelioma

Mesothelioma is a rare, aggressive and deadly cancer of the mesothelial tissue lining the internal organs and is incurable in most of the cases.

PET/CT Vs. CT: Comparing Treatment Response for Malignant Pleural Mesothelioma

PET/CT Vs. CT: Comparing Treatment Response for Malignant Pleural Mesothelioma

Evaluating tumor response and predicting prognosis in patients with unresectable malignant pleural mesothelioma, using CT and FDG-PET/CT techniques.
Can ADI-PEG20 Drug Treat Mesothelioma Cancer?

Can ADI-PEG20 Drug Treat Mesothelioma Cancer?

Mesothelioma treatment reaches new heights with a groundbreaking drug, offering hope and prolonged survival.
Nivolumab With Ipilimumab Have an Added Benefit in Mesothelioma

Nivolumab With Ipilimumab Have an Added Benefit in Mesothelioma

A pure antibody combination is approved as first-line therapy for unresectable malignant pleural mesothelioma for the first time. Added benefit is not yet proven for patients with epithelioid histology.
Advertisement
Nivolumab Found Effective to Treat Malignant Mesothelioma

Nivolumab Found Effective to Treat Malignant Mesothelioma

Nivolumab monotherapy is an effective treatment option for relapsed malignant mesothelioma (MM), according to research presented at the International Association for the Study of Lung Cancer World Conference on Lung Cancer.
Dual Immunotherapy for Treatment of Mesothelioma Patients

Dual Immunotherapy for Treatment of Mesothelioma Patients

Combination of two immunotherapy drugs nivolumab and ipilumumab offers better survival than chemotherapy for patients with malignant mesothelioma. This combination has shown clinical benefit in 6 cancers.
Durvalumab Combo Improved Survival in Mesothelioma

Durvalumab Combo Improved Survival in Mesothelioma

Phase 2 trial PrE0505 selected for oral presentation at ASCO 2020; data signals the combination of Durvalumab with pemetrexed and cisplatin could advance to a randomized phase 3 study.
Advertisement
Long-term Exposure to Asbestos may Trigger Lung Cancer

Long-term Exposure to Asbestos may Trigger Lung Cancer

Children, who have accidentally inhaled asbestos may see the effect after many years. Some can even develop lung cancer.
Radiation Enhances Survival Among Patients With Mesothelioma

Radiation Enhances Survival Among Patients With Mesothelioma

Aggressive radiotherapy for patients with malignant pleural mesothelioma improved the survival rate and controlled the symptoms significantly.
BAP1 Protein Linked to Tumor Suppression in Kidney, Eye, Bile Duct and Mesothelioma Cancers

BAP1 Protein Linked to Tumor Suppression in Kidney, Eye, Bile Duct and Mesothelioma Cancers

Researchers have identified a BAP1-mediated epigenetic mechanism linking ferroptosis to tumor suppression.
Advertisement
Health Concerns About Off-road Vehicles and Inhalation of Asbestos Raised

Health Concerns About Off-road Vehicles and Inhalation of Asbestos Raised

Off-road vehicles (ORVs) have been designed to operate in rugged, unpaved terrain, and people who use ORVs in many regions of the country may face exposure to hazardous mineral fibers.
Download Mesothelioma News Widget
Recommended Reading
Health News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Get Health and Wellness Secrets from Our Engaging eBooks
News Resource
Health News A-Z
Popular News
Latest Health News
Lifestyle and Wellness
Health Watch
Health In Focus
Celebrating Life
Breaking Health News
India Special
Medindia Exclusive - Interviews and In depth Reports
Sign up for Wellness Consult a Doctor Sign up for Selfcare

What's New on Medindia

View All

Articles

Stay Connected

Available on the Android Market Available on the App Store

Most Popular News

View All